AR010041A1 - Agonistas multifuncionales quimericos de receptores de hematopoyetina - Google Patents

Agonistas multifuncionales quimericos de receptores de hematopoyetina

Info

Publication number
AR010041A1
AR010041A1 ARP970104979A ARP970104979A AR010041A1 AR 010041 A1 AR010041 A1 AR 010041A1 AR P970104979 A ARP970104979 A AR P970104979A AR P970104979 A ARP970104979 A AR P970104979A AR 010041 A1 AR010041 A1 AR 010041A1
Authority
AR
Argentina
Prior art keywords
agonists
multifunctional
hematopoyetin
receptors
hematopoietin
Prior art date
Application number
ARP970104979A
Other languages
English (en)
Spanish (es)
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of AR010041A1 publication Critical patent/AR010041A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ARP970104979A 1996-10-25 1997-10-28 Agonistas multifuncionales quimericos de receptores de hematopoyetina AR010041A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2962996P 1996-10-25 1996-10-25

Publications (1)

Publication Number Publication Date
AR010041A1 true AR010041A1 (es) 2000-05-17

Family

ID=21850035

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970104979A AR010041A1 (es) 1996-10-25 1997-10-28 Agonistas multifuncionales quimericos de receptores de hematopoyetina

Country Status (17)

Country Link
EP (1) EP0935663A2 (ko)
JP (1) JP2001504689A (ko)
KR (1) KR100497423B1 (ko)
AR (1) AR010041A1 (ko)
AU (1) AU725547B2 (ko)
BR (1) BR9713668A (ko)
CA (1) CA2268742A1 (ko)
CZ (1) CZ295843B6 (ko)
IL (1) IL129565A0 (ko)
NO (1) NO991948L (ko)
NZ (1) NZ335382A (ko)
PL (1) PL333023A1 (ko)
RO (1) RO120919B1 (ko)
RU (2) RU2245887C2 (ko)
TW (2) TW200413407A (ko)
WO (1) WO1998017810A2 (ko)
ZA (1) ZA979607B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5581476A (en) 1993-01-28 1996-12-03 Amgen Inc. Computer-based methods and articles of manufacture for preparing G-CSF analogs
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP0973900A1 (en) * 1997-04-11 2000-01-26 G.D. Searle & Co. flt3 LIGAND CHIMERIC PROTEINS
BR9905867A (pt) * 1998-11-06 2001-01-23 Bio Sidus S A Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula
WO2002101047A1 (en) * 2001-06-12 2002-12-19 Smithkline Beecham Corporation Method of identifying compounds that modulate epo primary response gene 1, eprg1, activities
DE60236522D1 (de) 2001-07-11 2010-07-08 Maxygen Inc G-csf konjugate
JP4809767B2 (ja) 2003-08-18 2011-11-09 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 発現ベクター、ポリペプチドディスプレイライブラリ、並びにそれらの作製及び使用方法
RU2007149238A (ru) 2005-06-01 2009-07-20 Максиджен Холдингз Лтд. (Ky) Пегилированные полипептиды гксф и способы их получения
US7550433B2 (en) * 2005-06-03 2009-06-23 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
US7666817B2 (en) 2005-08-31 2010-02-23 The Regents Of The University Of California Cellular libraries of peptide sequences (CLiPS) and methods of using the same
WO2007098548A1 (en) * 2006-03-01 2007-09-07 Apollo Life Sciences Limited A molecule and chimeric molecules thereof
WO2009014726A1 (en) 2007-07-26 2009-01-29 The Regents Of The University Of California Methods for enhancing bacterial cell display of proteins and peptides
US10071109B2 (en) 2013-11-06 2018-09-11 Molecular Templates, Inc. Predictive biomarker for hypoxia-activated prodrug therapy
JP2022527322A (ja) * 2019-03-28 2022-06-01 オリオニス バイオサイエンシズ，インコーポレイテッド Ｆｍｓ様チロシンキナーゼ３リガンド（ｆｌｔ３ｌ）ベースキメラタンパク質

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006116A1 (en) * 1990-09-28 1992-04-16 Ortho Pharmaceutical Corporation Hybrid growth factors
US5376367A (en) * 1991-11-22 1994-12-27 Immunex Corporation Fusion proteins comprising MGF and IL-3
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US5635599A (en) * 1994-04-08 1997-06-03 The United States Of America As Represented By The Department Of Health And Human Services Fusion proteins comprising circularly permuted ligands

Also Published As

Publication number Publication date
AU725547B2 (en) 2000-10-12
TW591035B (en) 2004-06-11
CZ132399A3 (cs) 1999-12-15
KR20000052812A (ko) 2000-08-25
NO991948L (no) 1999-06-23
IL129565A0 (en) 2000-02-29
TW200413407A (en) 2004-08-01
JP2001504689A (ja) 2001-04-10
NZ335382A (en) 2001-03-30
RU2245887C2 (ru) 2005-02-10
CZ295843B6 (cs) 2005-11-16
RU2005105360A (ru) 2006-08-10
NO991948D0 (no) 1999-04-23
WO1998017810A3 (en) 1998-10-15
EP0935663A2 (en) 1999-08-18
KR100497423B1 (ko) 2005-07-07
WO1998017810A2 (en) 1998-04-30
AU5165298A (en) 1998-05-15
CA2268742A1 (en) 1998-04-30
BR9713668A (pt) 2000-03-08
ZA979607B (en) 1999-04-28
RO120919B1 (ro) 2006-09-29
PL333023A1 (en) 1999-11-08

Similar Documents

Publication Publication Date Title
AR010041A1 (es) Agonistas multifuncionales quimericos de receptores de hematopoyetina
IS1916B (is) Estrógen gerandefni/mótefni, notkun þeirra og milliefni til framleiðslu þeirra
DE69901714T2 (de) Elektrochemischer affinitätsassay
BR9712675A (pt) Agonistas do receptor de eritropoietina circularmente permutados.
DE69711519D1 (de) Carbazolanaloge als selektive beta3-adrenergische Agonisten
NO20006220L (no) <beta>2-adrenergistiske reseptoragonister
DK0964874T3 (da) CAML-bindende lymfocytoverfladereceptor, nukleinsyrer, som koder derfor, og fremgangsmåder til anvendelse deraf
DE69227347D1 (de) Auf rezeptorgrundlage arbeitende screening-verfahren für amylin-agonisten und- antagonisten
DK0760857T5 (da) Receptor for onkostatin M
ES2123482T3 (es) Receptor de estrogeno.
DK1145002T4 (da) Bioluminescenstest for agonister eller antagonister til en calciumkoblet receptor
BR9714355A (pt) Novos agonistas de receptor flt3
DE69506826D1 (de) 5-HT4 Rezeptoragonisten
SV1998000142A (es) Agonistas selectivos de beta3 adrenergicos ref. x-10907
DE69723527D1 (de) Halter für rohrförmige Komponenten
DK161860C (da) Fremgangsmaade til paavisning af det vigtigste ydre membranprotein af chlamydia trachomatis
BR9406616A (pt) Método para triagem de agonistas receptores
DK340987D0 (da) Tricykliske forbindelser, som er agonister af cholinerge receptorer, fremgangsmaade til fremstilling deraf, samt laegemidler indeholdende disse
ATE353364T1 (de) Transkriptions zwischen faktor-2 tif2
BR9808514A (pt) Proteìnas quiméricas do ligante flt3
DE69941406D1 (de) IL-6 Rezeptor IL-6-gekoppeltes Fusionsprotein
AU3249997A (en) Method of assaying compounds which affect the activity of g protein-coupled receptors based on measurement of receptor oligomerization
DE29609222U1 (de) Probenehmer für Flüssigkeiten
NO984233L (no) Cytokin kalt lerk-8
DE29780368U1 (de) Probenehmer für Flüssigkeiten

Legal Events

Date Code Title Description
FB Suspension of granting procedure